Ako, Junya

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Anand, S. S., Bosch, J., Eikelboom, J. W., Connolly, S. J., Diaz, R., Widimsky, P., Aboyans, V., Alings, M., Kakkar, A. K., Keltai, K., et al. (2018) · The Lancet

Antiplatelet Therapy and Cardiovascular DiseasesPeripheral Artery Disease Management

Cited by 879

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Connolly, S. J., Eikelboom, J. W., Bosch, J., Dagenais, G., Dyal, L., Lanas, F., Metsarinne, K., O'Donnell, M., Dans, A. L., Ha, J.-W., et al. (2018) · The Lancet

Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research

Cited by 754

JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome

Kimura, K., Kimura, T., Ishihara, M., Nakagawa, Y., Nakao, K., Miyauchi, K., Sakamoto, T., Tsujita, K., Hagiwara, N., Miyazaki, S., et al. (2019) · Circulation Journal

Acute Myocardial Infarction ResearchCoronary Interventions and Diagnostics

Cited by 565

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Ray, K. K., Colhoun, H. M., Szarek, M., Baccara-Dinet, M., Bhatt, D. L., Bittner, V. A., Budaj, A. J., Diaz, R., Goodman, S. G., Hanotin, C., et al. (2019) · The Lancet Diabetes & Endocrinology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 315

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Schwartz, G. G., Szarek, M., Bittner, V. A., Diaz, R., Goodman, S. G., Jukema, J. W., Landmesser, U., López-Jaramillo, P., Manvelian, G., Pordy, R., et al. (2021) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 150

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Hagström, E., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Danchin, N., Diaz, R., Goodman, S. G., Harrington, R. A., Jukema, J. W., et al. (2022) · Circulation

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 118

The GLIM criteria for defining malnutrition can predict physical function and prognosis in patients with cardiovascular disease

Kootaka, Y., Kamiya, K., Hamazaki, N., Nozaki, K., Ichikawa, T., Nakamura, T., Yamashita, M., Maekawa, E., Reed, J. L., Yamaoka-Tojo, M., et al. (2021) · Clinical Nutrition

Nutrition and Health in AgingClinical Nutrition and Gastroenterology

Cited by 81

Association between sarcopenia and atherosclerosis in elderly patients with ischemic heart disease

Uchida, S., Kamiya, K., Hamazaki, N., Matsuzawa, R., Nozaki, K., Ichikawa, T., Suzuki, Y., Nakamura, T., Yamashita, M., Kariya, H., et al. (2020) · Heart and Vessels

Nutrition and Health in AgingFrailty in Older Adults

Cited by 52

Non‐high‐density lipoprotein cholesterol: An important predictor of stroke and diabetes‐related mortality in Japanese elderly diabetic patients

Araki, A., Iimuro, S., Sakurai, T., Umegaki, H., Iijima, K., Nakano, H., Oba, K., Yokono, K., Sone, H., Yamada, N., et al. (2012) · Geriatrics & Gerontology International

Diabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular Health

Cited by 49

Liraglutide suppresses atrial electrophysiological changes

Nakamura, H., Niwano, S., Niwano, H., Fukaya, H., Murakami, M., Kishihara, J., Satoh, A., Yoshizawa, T., Ishizue, N., Igarashi, T., et al. (2019) · Heart and Vessels

Cardiac electrophysiology and arrhythmiasAtrial Fibrillation Management and Outcomes

Cited by 35